Managers / Q4 2023 · view latest →
Michelson Medical Research Foundation, Inc.
CIK 0001965304 · 11755 WILSHIRE BLVD., SUITE 1400, LOS ANGELES, CA, 90025 · (310) 806-9700
Summary
Michelson Medical Research Foundation, Inc. reported $152M in U.S.-listed holdings across 28 positions for Q4 2023.
The portfolio is heavily concentrated: IVE alone accounts for 37.8% of reported value.
Compared with Q3 2023, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 81.4% · $123M
- REIT · 13.3% · $20M
- Common Stock · 4.8% · $7M
- Closed-End Fund · 0.5% · $797,199
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GXCSPDR INDEX SHS FDS | NEW | +16.8K | 16.8K | +$1M | $1M |
| VEAVANGUARD TAX-MANAGED FDS | HELD | +0 | 361.2K | −$8M | $7M |
| KRESPDR SER TR | HELD | +0 | 114.7K | +$1M | $6M |
| IVEISHARES TR | HELD | +0 | 51.9K | +$1M | $9M |
| AREALEXANDRIA REAL ESTATE EQ IN | HELD | +0 | 37.2K | +$992,924 | $5M |
| ISHARES TR | HELD | +0 | 255.1K | +$936,327 | $20M |
| PLDPROLOGIS INC. | HELD | +0 | 42.4K | +$894,322 | $6M |
| IVVISHARES TR | HELD | +0 | 18.0K | +$867,070 | $9M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVEISHARES TR | IBOXX HI YD ETF · S&P 500 VAL ETF · CORE S&P500 ETF · CORE HIGH DV ETF · ISHARES BIOTECH · MICRO-CAP ETF · PFD AND INCM SEC | 37.85% | $57M | 559.0K |
| 2 | BKLNINVESCO EXCH TRADED FD TR IIhistory → | SR LN ETF | 8.39% | $13M | 600.6K |
| 3 | BSVVANGUARD BD INDEX FDShistory → | SHORT TRM BOND | 8.37% | $13M | 164.8K |
| 4 | VWOVANGUARD INTL EQUITY INDEX Fhistory → | FTSE EMR MKT ETF | 6.41% | $10M | 236.6K |
| 5 | EWZISHARES INC | MSCI BRAZIL ETF · MSCI MEXICO ETF · MSCI STH KOR ETF · MSCI JPN ETF NEW · MSCI TAIWAN ETF | 6.30% | $10M | 190.8K |
| 6 | KRESPDR SER TR | S&P REGL BKG · S&P BIOTECH | 5.81% | $9M | 146.0K |
| 7 | AVBAVALONBAY CMNTYS INChistory → | COM | 5.49% | $8M | 44.5K |
| 8 | VEAVANGUARD TAX-MANAGED FDShistory → | VAN FTSE DEV MKT | 4.81% | $7M | 361.2K |
| 9 | PLDPROLOGIS INC.history → | COM | 3.73% | $6M | 42.4K |
| 10 | AREALEXANDRIA REAL ESTATE EQ INhistory → | COM | 3.11% | $5M | 37.2K |
| 11 | VBVANGUARD INDEX FDShistory → | SMALL CP ETF | 2.66% | $4M | 18.9K |
| 12 | CRCCALIFORNIA RES CORPhistory → | COM STOCK | 2.11% | $3M | 58.5K |
| 13 | CRGYCRESCENT ENERGY COMPANYhistory → | CL A COM | 1.36% | $2M | 156.2K |
| 14 | TALOTALOS ENERGY INChistory → | COM | 1.31% | $2M | 139.8K |
| 15 | BXPBOSTON PROPERTIES INChistory → | COM | 1.01% | $2M | 21.7K |
| 16 | GXCSPDR INDEX SHS FDS | S&P CHINA ETF | 0.75% | $1M | 16.8K |
| 17 | NMLNEUBERGER BERMAN ENERGY INFR | COM | 0.53% | $797,199 | 115.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $99M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $100M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $115M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 20 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $120M | 25 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 28 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $142M | 28 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $165M | 28 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $152M | 28 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $148M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $141M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128M | 21 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $154M | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.